A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

August 12, 2020

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2024

Conditions

Alopecia Areata(AA)

Interventions

DRUG

Jaktinib hydrochloride cream

Jaktinib hydrochloride cream/placebo applied topically in the morning and in the evening, administered continuously for 24 weeks

DRUG

Placebo

Dose extension: Placebo

Trial Locations (1)

The Second Xaingya Hospital，central south university, Changsha

All Listed Sponsors

lead

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

INDUSTRY